Cryptococcal meningitis is the most common central nervous system infection in the world
today. It occurs primarily, but not exclusively, in immunocompromised individuals and despite …

Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs)
on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …

Cryptococcal infections burden the immunocompromised population with unacceptably
high morbidity and mortality. This population includes HIV-infected individuals and those …

The tolerability of available antifungal agents is essential to the final outcome of the management
of invasive mycoses. There are limited classes of antifungal agents for use, and they …

Background Tixagevimab–cilgavimab is a neutralising monoclonal antibody combination
hypothesised to improve outcomes for patients hospitalised with COVID-19. We aimed to …

A 36-year-old previously healthy woman with no personal or family history of mental illness
presented with new-onset psychosis after a diagnosis of symptomatic COVID-19. Her …

Importance Limited effective therapeutics are available to hospitalized patients with COVID-19.
Clinical trials and observational studies have shown varying effects of systemic …

Importance The effect of higher-dose fluvoxamine in reducing symptom duration among
outpatients with mild to moderate COVID-19 remains uncertain. Objective To assess the …

Medicine is a field that has evolved through the ages and continues to do so with the
advancement of basic, clinical, and technological sciences. Accordingly, the roles and …

Background Nontuberculous mycobacteria (NTM) are opportunistically pathogenic bacteria
that are found abundantly in the soil and water. Susceptible individuals exposed to NTM-…